Swedish precision oncology firm, Beactica Therapeutics AB, has today unveiled BEA-17 as their chosen preclinical candidate within the LSD1 initiative

Daiichi Sankyo Co., Ltd. is a pharmaceutical organization based in Tokyo-to, Japan.

ACM Biolabs has revealed encouraging preliminary findings from a Phase I evaluation of ACM-001, their inaugural clinical-stage development initiative.

This article summarized the latest R&D progress of Pemafibrate, the Mechanism of Action for Pemafibrate, and the drug target R&D trends for Pemafibrate.

Is it sufficient to solely search for nucleotide sequences when searching for a specific nucleotide sequence? Certainly not.

InvIOs GmbH revealed today that it has launched patient enrollment for a Phase 1b trial of its innovative autologous cell therapy, APN401, focusing on solid tumor patients.

Hypercholesterolemia refers to a condition in which the cholesterol level in the blood is abnormally elevated.

Relay Therapeutics is a well-known drug discovery company in recent years, characterized by computational chemistry, with three drugs in its pipeline all from D.E. Shaw.

Nalbuphine Hydrochloride is a small molecule drug that targets both the κ opioid receptor and μ opioid receptor.

The European Union Commission has approved Pfizer's ABRYSVO™ to protect infants and the elderly from Respiratory Syncytial Virus infections via maternal vaccination.

Homology is a qualitative concept where we determine whether two sequences are homologous or not. However, the similarity between homologous sequences can be measured using techniques such as sequence alignment. One popular method for aligning sequences is using BLAST.

Bristol Myers Squibb Co. is a pharmaceutical organization that was founded in 1887 and is headquartered in New York, United States.